[D1442-2am] 16. Natural Products Chemistry, Chemical Biology

[D1442-2am-14] Development of hydroxyl group deprotection mechanism triggered by endogenous acrolein

^○Yuria TAKAHASHI¹, Kazuki TERASHIMA¹, Ambara Rachmat PRADIPTA¹, Katsunori TANAKA^1,2 (1. Tokyo Institute of Technology, School of Materials and Chemical Technology, Department of Chemical Science and Engineering, 2. RIKEN Cluster for Pioneering Research, Biofunctional Synthetic Chemistry Laboratory)

[Lang.] Japanese

Keywords:Cancer therapy, Prodrug, Breast cancer, 1,3-dipolar cycloaddition, In vivo synthesis